senate Bill S5553A

2015-2016 Legislative Session

Directs the health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of mitochondrial disease

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Senate Committee Insurance Committee


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (7)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jun 07, 2016 print number 5553b
Jun 07, 2016 amend (t) and recommit to insurance
May 10, 2016 reported and committed to insurance
Jan 15, 2016 print number 5553a
Jan 15, 2016 amend and recommit to health
Jan 06, 2016 referred to health
May 14, 2015 referred to health

Votes

view votes

May 10, 2016 - Health committee Vote

S5553A
14
0
committee
14
Aye
0
Nay
1
Aye with Reservations
0
Absent
2
Excused
0
Abstained
show Health committee vote details

Health Committee Vote: May 10, 2016

aye wr (1)
excused (2)

S5553 - Details

See Assembly Version of this Bill:
A7689
Current Committee:
Senate Insurance
Law Section:
Health
Versions Introduced in 2017-2018 Legislative Session:
S1316, A2850

S5553 - Summary

Directs the health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of mitochondrial disease.

S5553 - Sponsor Memo

S5553 - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  5553

                       2015-2016 Regular Sessions

                            I N  S E N A T E

                              May 14, 2015
                               ___________

Introduced  by  Sen.  LITTLE -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health

AN ACT to direct the commissioner of health and  the  superintendent  of
  financial  services  to  study and report upon the impact of requiring
  that certain health insurance plans provide coverage for treatment  of
  mitochondrial disease

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The commissioner of health and the superintendent of finan-
cial services shall cause a study to  be  performed  on  the  impact  of
requiring  that  certain  health  insurance  plans  provide coverage for
treatment of mitochondrial disease. Such study shall include an  assess-
ment  of  the impact of such a requirement on costs to insurance provid-
ers, the cost of insurance premiums, and the fiscal impact to the state.
  S 2. On or before November 30, 2015, the commissioner  of  health  and
the  superintendent  of  financial  services  shall  complete  the study
conducted pursuant to section one  of  this  act  and  shall  thereafter
deliver  a  copy of the findings of the study and any legislative recom-
mendations they deem to be necessary  to  the  governor,  the  temporary
president of the senate, and the speaker of the assembly.
  S 3. This act shall take effect immediately.




 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD11057-02-5

S5553A - Details

See Assembly Version of this Bill:
A7689
Current Committee:
Senate Insurance
Law Section:
Health
Versions Introduced in 2017-2018 Legislative Session:
S1316, A2850

S5553A - Summary

Directs the health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of mitochondrial disease.

S5553A - Sponsor Memo

S5553A - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 5553--A

                       2015-2016 Regular Sessions

                            I N  S E N A T E

                              May 14, 2015
                               ___________

Introduced  by  Sen.  LITTLE -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health --  recommitted  to
  the  Committee  on  Health in accordance with Senate Rule 6, sec. 8 --
  committee discharged, bill amended, ordered reprinted as  amended  and
  recommitted to said committee

AN  ACT  to  direct the commissioner of health and the superintendent of
  financial services to study and report upon the  impact  of  requiring
  that  certain health insurance plans provide coverage for treatment of
  mitochondrial disease

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The commissioner of health and the superintendent of finan-
cial  services  shall  cause  a  study  to be performed on the impact of
requiring that certain  health  insurance  plans  provide  coverage  for
treatment  of mitochondrial disease. Such study shall include an assess-
ment of the impact of such a requirement on costs to  insurance  provid-
ers, the cost of insurance premiums, and the fiscal impact to the state.
  S  2.  On  or before November 30, 2016, the commissioner of health and
the superintendent  of  financial  services  shall  complete  the  study
conducted  pursuant  to  section  one  of  this act and shall thereafter
deliver a copy of the findings of the study and any  legislative  recom-
mendations  they  deem  to  be  necessary to the governor, the temporary
president of the senate, and the speaker of the assembly.
  S 3. This act shall take effect immediately.



 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD11057-03-6

Co-Sponsors

S5553B (ACTIVE) - Details

See Assembly Version of this Bill:
A7689
Current Committee:
Senate Insurance
Law Section:
Health
Versions Introduced in 2017-2018 Legislative Session:
S1316, A2850

S5553B (ACTIVE) - Summary

Directs the health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of mitochondrial disease.

S5553B (ACTIVE) - Sponsor Memo

S5553B (ACTIVE) - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 5553--B

                       2015-2016 Regular Sessions

                            I N  S E N A T E

                              May 14, 2015
                               ___________

Introduced  by  Sen.  LITTLE -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health --  recommitted  to
  the  Committee  on  Health in accordance with Senate Rule 6, sec. 8 --
  committee discharged, bill amended, ordered reprinted as  amended  and
  recommitted  to said committee -- reported favorably from said commit-
  tee  and  committed  to  the  Committee  on  Insurance  --   committee
  discharged, bill amended, ordered reprinted as amended and recommitted
  to said committee

AN ACT to amend the insurance law, in relation to directing the New York
  state health care quality and cost containment commission to study and
  report  upon  the  impact  of  requiring that certain health insurance
  plans provide coverage for treatment of mitochondrial disease

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 213 of the insurance law is amended by adding a new
subdivision (e) to read as follows:
  (E)  THE  COMMISSION SHALL CAUSE A STUDY TO BE PERFORMED ON THE IMPACT
OF REQUIRING CERTAIN HEALTH INSURANCE  PLANS  TO  PROVIDE  COVERAGE  FOR
TREATMENT  OF MITOCHONDRIAL DISEASE. SUCH STUDY SHALL INCLUDE AN ASSESS-
MENT OF THE IMPACT OF SUCH A REQUIREMENT ON COSTS TO PROVIDERS, THE COST
OF INSURANCE PREMIUMS, AND THE FISCAL IMPACT TO THE STATE.  THE  COMMIS-
SION  SHALL SUBMIT A REPORT OF THE FINDINGS, CONCLUSIONS AND RECOMMENDA-
TION OF SUCH STUDY, ON OR BEFORE NOVEMBER THIRTIETH, TWO THOUSAND SEVEN-
TEEN, TO THE GOVERNOR,  THE  TEMPORARY  PRESIDENT  OF  THE  SENATE,  THE
SPEAKER OF THE ASSEMBLY, THE CHAIRS OF THE SENATE AND ASSEMBLY INSURANCE
COMMITTEES, AND THE CHAIRS OF THE SENATE AND ASSEMBLY HEALTH COMMITTEES.
  S 2. This act shall take effect immediately.


 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD11057-05-6

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.